Cannabis drug filed for approval — BBC News
The first cannabis-based medication for MS has been filed for approval by British regulators.
GW Pharmaceuticals’ Sativex, an under-the-tongue spray, can now be given on a named-patient basis. But the company is applying to regulators across Europe for a licence to make it more widely available.
The company has been seeking a full UK licence for the spray since 2003, but regulators said they wanted to see more information before issuing one. Eighty-five thousand people in the UK have MS. It is not yet certain how many of them would benefit from Sativex.
The spray is intended to treat the muscle spasticity associated with the degenerative disease.
………
http://news.bbc.co.uk/go/pr/fr/-/2/hi/health/5319786.stm